Table 3.
Socioeconomic gradients in risk ratios for amenable mortality by income and cause of death, women aged 25-74
| |
|
Period I: 1992 - 95 |
Period II: 1996 - 99 |
Period III: 2000 - 03 |
Period interactions |
||||
|---|---|---|---|---|---|---|---|---|---|
| Income | RR | 95% CI | RR | 95% CI | RR | 95% CI | P value | ||
| All cause mortality |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
<.001 |
| |
4 |
1.27 |
(1.09 - 1.47 ) |
1.28 |
(1.10 - 1.48 ) |
1.29 |
(1.12 - 1.49 ) |
PII vs PIII |
0.12 |
| |
3 |
1.52 |
(1.34 - 1.73 ) |
1.55 |
(1.36 - 1.76 ) |
1.54 |
(1.34 - 1.77 ) |
PI vs PIII |
<.001 |
| |
2 |
1.82 |
(1.60 - 2.06 ) |
1.98 |
(1.74 - 2.25 ) |
2.00 |
(1.70 - 2.35 ) |
|
|
| |
1 |
2.53 |
(2.24 - 2.86 ) |
2.98 |
(2.63 - 3.38 ) |
3.26 |
(2.68 - 3.96 ) |
|
|
| Total disease mortality |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
<.001 |
| |
4 |
1.29 |
(1.11 - 1.50 ) |
1.29 |
(1.11 - 1.49 ) |
1.30 |
(1.14 - 1.48 ) |
PII vs PIII |
0.24 |
| |
3 |
1.53 |
(1.34 - 1.74 ) |
1.55 |
(1.37 - 1.75 ) |
1.53 |
(1.34 - 1.75 ) |
PI vs PIII |
<.001 |
| |
2 |
1.80 |
(1.58 - 2.05 ) |
1.93 |
(1.71 - 2.18 ) |
1.95 |
(1.67 - 2.27 ) |
|
|
| |
1 |
2.47 |
(2.18 - 2.81 ) |
2.91 |
(2.58 - 3.28 ) |
3.12 |
(2.58 - 3.76 ) |
|
|
| Total amenable mortality |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
<.001 |
| |
4 |
1.19 |
(1.04 - 1.38 ) |
1.19 |
(1.04 - 1.38 ) |
1.24 |
(1.12 - 1.38 ) |
PII vs PIII |
0.05 |
| |
3 |
1.37 |
(1.22 - 1.55 ) |
1.43 |
(1.25 - 1.64 ) |
1.47 |
(1.31 - 1.65 ) |
PI vs PIII |
<.001 |
| |
2 |
1.52 |
(1.34 - 1.72 ) |
1.62 |
(1.42 - 1.85 ) |
1.77 |
(1.56 - 2.01 ) |
|
|
| |
1 |
2.22 |
(1.97 - 2.51 ) |
2.57 |
(2.26 - 2.92 ) |
2.93 |
(2.53 - 3.40 ) |
|
|
| Early detection and intervention |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
0.04 |
| |
4 |
1.17 |
(1.04 - 1.32 ) |
1.19 |
(1.06- 1.35 ) |
1.20 |
(1.08 - 1.34 ) |
PII vs PIII |
0.17 |
| |
3 |
1.33 |
(1.20 - 1.46 ) |
1.39 |
(1.23 - 1.57 ) |
1.38 |
(1.23 - 1.55 ) |
PI vs PIII |
<.001 |
| |
2 |
1.40 |
(1.27- 1.54) |
1.49 |
(1.32 - 1.67 ) |
1.58 |
(1.41 - 1.76 ) |
|
|
| |
1 |
1.80 |
(1.63 - 1.99 ) |
1.99 |
(1.73- 2.29 ) |
2.19 |
(1.93 - 2.48 ) |
|
|
| - malignant neoplasm |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
* |
1.00 |
|
1.00 |
|
PI vs PII |
0.01 |
| |
4 |
1.11 |
(0.96 - 1.29 ) |
1.19 |
(1.01 - 1.40 ) |
1.13 |
(0.96 - 1.32 ) |
PII vs PIII |
<.001 |
| |
3 |
1.23 |
(1.08 - 1.39 ) |
1.40 |
(1.98 - 1.65 ) |
1.31 |
(1.09 - 1.56 ) |
PI vs PIII |
<.001 |
| |
2 |
1.10 |
(0.96 - 1.26 ) |
1.28 |
(1.08 - 1.52 ) |
1.37 |
(1.14 - 1.63 ) |
|
|
| |
1 |
1.06 |
(0.91 - 1.24 ) |
1.29 |
(1.10 - 1.52 ) |
1.57 |
(1.31 - 1.87 ) |
|
|
| - hypertension and cerebrovascular disease |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
0.11 |
| |
4 |
1.29 |
(1.07 - 1.57 ) |
1.23 |
(1.01 - 1.51 ) |
1.49 |
(1.32 - 1.66 ) |
PII vs PIII |
0.21 |
| |
3 |
1.55 |
(1.31 - 1.82 ) |
1.46 |
(1.26 - 1.71 ) |
1.74 |
(1.57 - 1.94 ) |
PI vs PIII |
0.01 |
| |
2 |
1.87 |
(1.62 - 2.15 ) |
1.92 |
(1.69 - 2.18 ) |
2.26 |
(2.01 - 2.53 ) |
|
|
| |
1 |
2.83 |
(2.46 - 3.26 ) |
3.16 |
(2.72 - 3.66 ) |
3.75 |
(3.15 - 4.45 ) |
|
|
| Improved treatment and medical care |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
<.001 |
| |
4 |
1.35 |
(0.91 - 2.01 ) |
1.14 |
(0.73 - 1.77 ) |
1.71 |
(1.11 - 2.64 ) |
PII vs PIII |
<.001 |
| |
3 |
1.71 |
(1.17 - 2.49 ) |
1.73 |
(1.15 - 2.61 ) |
2.46 |
(1.82 - 3.31 ) |
PI vs PIII |
<.001 |
| |
2 |
2.41 |
(1.66 - 3.51 ) |
2.60 |
(1.76 - 3.83 ) |
4.02 |
(2.90 - 5.56 ) |
|
|
| |
1 |
5.44 |
(3.79 - 7.81 ) |
6.70 |
(4.55 - 9.88 ) |
11.41 |
(8.15 - 16.0 ) |
|
|
| - predominantly primary care |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
0.41 |
| |
4 |
1.20 |
(0.69 - 2.07 ) |
1.52 |
(0.91 - 2.55 ) |
2.14 |
(1.08 - 4.23 ) |
PII vs PIII |
<.001 |
| |
3 |
1.56 |
(0.89 - 2.73 ) |
1.99 |
(1.17 - 3.38 ) |
3.43 |
(1.79 - 6.57 ) |
PI vs PIII |
<.001 |
| |
2 |
2.85 |
(1.60 - 5.07 ) |
3.55 |
(2.18 - 5.80 ) |
8.42 |
(4.33 - 16.4 ) |
|
|
| |
1 |
4.55 |
(2.79 - 7.42 ) |
6.01 |
(3.88 - 9.33 ) |
20.54 |
(11.4 - 36.8 ) |
|
|
| - predominantly specialist care |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
0.01 |
| |
4 |
1.40 |
(0.90 - 2.18 ) |
1.06 |
(0.65 - 1.73 ) |
1.66 |
(1.05 - 2.62 ) |
PII vs PIII |
0.06 |
| |
3 |
1.74 |
(1.14 - 2.66 ) |
1.70 |
(1.07 - 2.71 ) |
2.32 |
(1.70 - 3.17 ) |
PI vs PIII |
<.001 |
| |
2 |
2.37 |
(1.55 - 3.62 ) |
2.51 |
(1.64 - 3.81 ) |
3.58 |
(2.56 - 5.02 ) |
|
|
| |
1 |
5.62 |
(3.72 - 8.49 ) |
6.90 |
(4.50 – 10.6 ) |
10.36 |
(7.14 - 15.0 ) |
|
|
| Ischaemic heart disease |
|
|
|
|
|
|
|
|
|
| |
5 |
1.00 |
|
1.00 |
|
1.00 |
|
PI vs PII |
<.001 |
| |
4 |
1.40 |
(1.24-1.58) |
1.49 |
(1.30-1.70) |
1.57 |
(1.39-1.78) |
PII vs PIII |
<.001 |
| |
3 |
1.71 |
(1.54-1.90) |
1.91 |
(1.67-2.18) |
2.01 |
(1.77-2.29) |
PI vs PIII |
<.001 |
| |
2 |
2.15 |
(1.92-2.40) |
2.51 |
(2.18-2.90) |
2.81 |
(2.43-3.25) |
|
|
| 1 | 2.51 | (2.27-2.80) | 2.97 | (2.61-3.39) | 4.01 | (3.51-4.59) | |||
* linear income trend not significant at 95% significance level.
Socioeconomic differences in amenable mortality by income and cause of death. women aged 25-74.